Document › Details

Medigene AG. (11/8/13). "Press Release: Medigene Reports Financial Results for the First Nine Months of 2013". Martinsried.

	Organisation	Medigene AG (FSE: MDG1, Prime Standard)
	Group	Medigene (Group)
	Organisation 2	SynCore Biotechnology Co., Ltd.
	Group	Sinphar Pharmaceutical (Group)
	Product	Veregen®
	Product 2	EndoTAG™-1
	Person	Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex)
	Person 2	Hofmann, Julia (Medigene 201604 PR/IR)

Original document
accessed by [iito] on 2013-11-08

Record changed: 2019-06-09

More documents for Medigene (Group)

[1] Medigene AG. (5/14/19). "Press Release: Medigene Reports Financial & Business Results for the First Three Months of 2019". Martinsried....
[2] Medigene AG. (5/9/19). "Press Release: Bluebird Presents Preclinical Data of First TCR Candidate from Medigene Collaboration. Start Clinical Development 2020". Martinsried....
[3] Medigene AG. (5/8/19). "Press Release: Medigene Participates at Upcoming Conferences". Martinsried....
[4] Medigene AG. (5/2/19). "Press Release: Medigene Presented Data on Favorable Safety Pattern of PRAME-specific TCR on Neuronal Cells at 2019 ASGCT Meeting". Martinsried....
[5] Medigene AG. (4/4/19). "Press Release: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia". Martinsried & Hong Kong....
[6] Medigene AG. (2/25/19). "Press Release: European Patent Covering TCR Library Suitable for the Development of Neoantigen-specific TCRs". Martinsried....
[7] Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried....
[8] Medigene AG. (1/17/19). "Press Release: Medigene Participates at Four Upcoming Conferences". Martinsried....
[9] Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg....
[10] Medigene AG. (12/19/18). "Press Release: Medigene Publishes Topline Interim Data from Ongoing Phase I/II Clinical Trial with DC Vaccines in AML Patients". Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]